These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30502632)

  • 1. Synthesis, molecular modeling and BACE-1 inhibitory study of tetrahydrobenzo[b] pyran derivatives.
    Bhaskar V; Chowdary R; Dixit SR; Joshi SD
    Bioorg Chem; 2019 Mar; 84():202-210. PubMed ID: 30502632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors.
    Bertini S; Ghilardi E; Asso V; Minutolo F; Rapposelli S; Digiacomo M; Saccomanni G; Salmaso V; Sturlese M; Moro S; Macchia M; Manera C
    Bioorg Med Chem Lett; 2017 Nov; 27(21):4812-4816. PubMed ID: 28993050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation.
    Edraki N; Firuzi O; Fatahi Y; Mahdavi M; Asadi M; Emami S; Divsalar K; Miri R; Iraji A; Khoshneviszadeh M; Firoozpour L; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2015 May; 348(5):330-7. PubMed ID: 25787800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors.
    Jain P; Wadhwa PK; Rohilla S; Jadhav HR
    Bioorg Med Chem Lett; 2016 Jan; 26(1):33-7. PubMed ID: 26614409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
    Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
    Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, synthesis and biological evaluation of novel β-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand.
    Ghosh AK; Brindisi M; Yen YC; Xu X; Huang X; Devasamudram T; Bilcer G; Lei H; Koelsch G; Mesecar AD; Tang J
    Bioorg Med Chem Lett; 2015 Feb; 25(3):668-72. PubMed ID: 25537272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides.
    Bertini S; Ghilardi E; Asso V; Granchi C; Minutolo F; Pineschi M; Di Bussolo V; Bortolato A; Moro S; Saba A; Macchia M
    Bioorg Med Chem; 2010 Nov; 18(22):7991-6. PubMed ID: 20934348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel peptidomimetics as BACE-1 inhibitors: synthesis, molecular modeling, and biological studies.
    Butini S; Gabellieri E; Brindisi M; Casagni A; Guarino E; Huleatt PB; Relitti N; La Pietra V; Marinelli L; Giustiniano M; Novellino E; Campiani G; Gemma S
    Bioorg Med Chem Lett; 2013 Jan; 23(1):85-9. PubMed ID: 23218605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An environmentally benign protocol for aqueous synthesis of tetrahydrobenzo[b]pyrans catalyzed by cost-effective ionic liquid.
    Hu H; Qiu F; Ying A; Yang J; Meng H
    Int J Mol Sci; 2014 Apr; 15(4):6897-909. PubMed ID: 24758931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of synthesis, biological assay and QSAR studies of β-secretase inhibitors.
    Niño H; García-Pintos I; Rodríguez-Borges JE; Escobar-Cubiella M; García-Mera X; Prado-Prado F
    Curr Comput Aided Drug Des; 2011 Dec; 7(4):263-75. PubMed ID: 22050682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches.
    Tran TS; Le MT; Tran TD; Tran TH; Thai KM
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32785161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in the Generation of Amyloid-β Due to Salvianolic Acid B by Modulating BACE1 Activity.
    Durairajan SSK; Chirasani VR; Shetty SG; Iyaswamy A; Malampati S; Song J; Liu L; Huang J; Senapati S; Li M
    Curr Alzheimer Res; 2017; 14(11):1229-1237. PubMed ID: 28413985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
    Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
    Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.
    Azimi S; Zonouzi A; Firuzi O; Iraji A; Saeedi M; Mahdavi M; Edraki N
    Eur J Med Chem; 2017 Sep; 138():729-737. PubMed ID: 28728105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure guided P1' modifications of HEA derived β-secretase inhibitors for the treatment of Alzheimer's disease.
    Monenschein H; Horne DB; Bartberger MD; Hitchcock SA; Nguyen TT; Patel VF; Pennington LD; Zhong W
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3607-11. PubMed ID: 22572583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of 1,3-disubstituted 2-propanols as BACE-1 inhibitors.
    Kumar AB; Anderson JM; Melendez AL; Manetsch R
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4740-4. PubMed ID: 22727644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of Succinimide as A Green and Sustainable Organo-Catalyst for the Synthesis of Arylidene Malononitrile and Tetrahydrobenzo[b] pyran Derivatives.
    Hassanzadeh F; Shirini F; Mamaghani M; Daneshvar N
    Comb Chem High Throughput Screen; 2021; 24(1):155-163. PubMed ID: 32646356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.